In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

6,070 results for your search

... before the second episode - Don't wait for recurrences!

Event : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Kuck (Hamburg,DE)

...always endocardial first

Event : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Zeppenfeld (Leiden,NL)

10-year performance of Durata versus Riata implantable cardioverter defibrillator leads in clinical practice

Event : EHRA 2019

  • Session : Device Complications and Lead Extraction
  • Speaker : T Kleemann (Ludwigshafen,DE)

10-year trends in the use of catheter ablation for the treatment ofVT versus other ablation procedures and PCI for the treatment of IHD

Event : EHRA 2019

  • Session : Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
  • Speaker : R Anderson (Melbourne,AU)

1969-2019: 50 years since the first discovery of cardiac calcium current activation by adrenaline

Event : EHRA 2019

  • Session : Carmeliet-Coraboeuf-Weidmann lecture
  • Speaker : R Fischmeister (Chatenay-Malabry,FR)

2019 Forecast.

Event : EHRA 2019

  • Session : EHRA General Assembly
  • Speaker : H Puererfellner (Linz,AT)

3D vectorcardiography confirms electrical synchronization achieved by dynamic programming of atrioventricular delay

Event : EHRA 2019

  • Session : Moderated ePosters 7: contemporary cardiac resynchronization therapy: is there room for improvement?
  • Speaker : F Prinzen (Maastricht,NL)

60 year male, cardiomyopathy, LVEF 35% and persistent atrial fibrillation

Event : EHRA 2019

  • Session : Case-based optimal therapy of atrial fibrillation
  • Speaker : S Trines (Leiden,NL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are